Apellis Pharmaceuticals Inc (APLS)
38.36
-3.16
(-7.61%)
USD |
NASDAQ |
Jun 28, 16:00
38.89
+0.53
(+1.38%)
After-Hours: 20:00
Apellis Pharmaceuticals Research and Development Expense (% of Annual Revenues)
Research and Development Expense (% of Annual Revenues) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (% of Annual Revenues) Data
Date | Value |
---|---|
December 31, 2023 | -- |
December 31, 2022 | -- |
Date | Value |
---|---|
December 31, 2021 | -- |
December 31, 2020 | -- |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.